Form 144: Edward Schlesinger to sell 21,104 GLW shares

Edward Schlesinger has filed a Form 144 to sell up to 21,104 common shares of GLW through UBS Financial Services Inc. on or about 01/29/2026 on the NYSE, with an aggregate market value of $2,206,301.80.

Rhea-AI Filing Summary

Edward Schlesinger has filed a Form 144 to sell up to 21,104 common shares of GLW through UBS Financial Services Inc. on or about 01/29/2026 on the NYSE, with an aggregate market value of $2,206,301.80. These shares come from a 01/29/2026 stock option exercise for 8,925 shares and a 04/15/2025 performance stock release for 12,179 shares, both from the issuer. Over the prior three months, Schlesinger sold 20,893 common shares for gross proceeds of $1,906,461.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GLW Form 144 filing by Edward Schlesinger disclose?

The filing discloses that Edward Schlesinger plans to sell up to 21,104 GLW common shares. The planned sale has an aggregate market value of about $2.21 million and will be executed through UBS Financial Services Inc. on or around January 29, 2026.

How many GLW shares is Edward Schlesinger planning to sell under this Form 144?

Edward Schlesinger intends to sell up to 21,104 GLW common shares. These shares are expected to be sold on or about January 29, 2026, on the NYSE, with an indicated aggregate market value of approximately $2,206,301.80 at the time of the notice.

What is the value of the GLW shares Edward Schlesinger plans to sell?

The Form 144 shows an aggregate market value of $2,206,301.80 for the 21,104 GLW common shares. This figure reflects the market value at the time of the notice and is tied to the intended NYSE sale around January 29, 2026.

When were the GLW shares in Edward Schlesinger’s Form 144 acquired?

The shares were acquired in two transactions: 8,925 shares on January 29, 2026 via a stock option exercise, and 12,179 shares on April 15, 2025 through a performance stock release. Both acquisitions are identified as coming directly from the issuer.

Has Edward Schlesinger sold GLW shares in the past three months?

Yes. The filing reports that Edward Schlesinger sold 20,893 GLW common shares on October 31, 2025. Those shares generated gross proceeds of $1,906,461, and this prior activity is disclosed as part of the three-month sale history requirement.

How many GLW shares are outstanding compared with the planned Form 144 sale?

The notice lists 857,360,396 GLW common shares outstanding. Within this context, Edward Schlesinger’s planned sale covers 21,104 shares, and the sale is slated to occur on the NYSE using UBS Financial Services Inc. as broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 10:37 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001658538
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corning Incorporated
SEC File Number	001-03247
Address of Issuer	One Riverfront Plaza Corning NEW YORK 14831
Phone	607-974-7430
Name of Person for Whose Account the Securities are To Be Sold	Edward Schlesinger
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	21104	2206301.8	857360396	01/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	01/29/2026	stock option exercise	issuer			8925	01/29/2026	n/a
common	04/15/2025	performance stock release	issuer			12179	04/15/2025	N/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Edward Schlesinger One Riverfront Plaza Corning NY 14831	common	10/31/2025	20893	1906461

144: Remarks and Signature

Remarks
Date of Notice	01/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Edward Schlesinger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)